Preteen girls are more likely than older teens and women to experience adverse side effects within two weeks of receiving Merck’s Gardasil® vaccine, a new Kaiser Permanente study has found.
Gardasil®, which is typically administered in a three-shot series, is intended to ward off human papillomavirus (HPV) infection and prevent cervical cancer. Since its debut in 2006, however, the costly vaccine has drawn intense criticism from many doctors, medical researchers, consumer groups, and parents for posing too many health risks while providing little to no benefit.
The Kaiser study surveyed 899 girls and women ages 11 to 26 who received the Gardasil® vaccine within two weeks of receiving the injection in the upper arm. Seventy-eight percent of the patients reported pain when receiving the vaccine; 17 percent reported bruising or discoloration; 14 percent reported swelling at the injection site; 15 percent reported dizziness, and 1 percent of the girls fainted.
Pain during the injection was reported by 84 percent of girls aged 11 to 12 versus 74 percent of women aged 18 to 26. Nineteen percent of girls ages 11 to 12 experienced dizziness after receiving the vaccine compared to 8 percent of women ages 18 to 26.
Despite Gardasil’s® well documented risks, however, many medical professionals continue to peddle the vaccine and overstate its benefit. Kaiser Permanente emphasizes that the adverse reactions reported by its study’s participants were mild and comparable to those of other vaccines.
“Gardasil is an important cancer-prevention vaccine, but too few girls are getting it. Our study found that young girls do have some knowledge about the vaccine, but they need to know more. If these girls and their parents know what to expect, they will likely be less afraid of getting the vaccine,” one the Kaiser study’s lead author said.
But while Pfizer lobbyists and the doctors who shill for them continue to promote Gardasil®, a growing body of evidence indicates many young girls and even boys are being exposed to potentially deadly side effects while receiving little to no benefit from the injections.
A database jointly operated by the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration has logged more than 20,000 reports of adverse events associated with the Gardasil vaccine, including seizures, strokes, dizziness, fatigue, weakness, headaches, nausea, joint pain, auto-immune disorders, blood clots, cardiac distress, paralysis, loss of consciousness, swollen lymph nodes, Guillain–Barre syndrome, transverse myelitis, facial palsy, chronic fatigue syndrome, and anaphylaxis, to name just a few. Seventy-one deaths are also blamed on the Gardasil vaccine, according to the Vaccine Adverse Event Reporting System (VAERS).
A recent Gardasil® benefit/risk analysis conducted by researchers at the University of British Columbia’s Neural Dynamics Research determined that “cervical cancer is a rare disease with mortality rates that are several times lower than the rate of reported serious adverse reactions (including deaths) from HPV vaccination.”
Dr. Diane Harper, a lead developer of the Gardasil® vaccine and now one of its most outspoken critics, has said “the best way to prevent cervical cancer is with routine Pap screening starting at age 21 years. Vaccination cannot prevent as many cervical cancers as can Pap screening.”
“Pap screening with vaccination does NOT lower your chances of cervical cancer; pap screening and vaccination lowers your chances of an abnormal Pap test,” Dr. Harper told TheTruthAboutGardasil.org. “Gardasil® is associated with GBS [Guillian-Barre Syndrome] that has resulted in deaths. Pap screening using a speculum and taking cells from the cervix is not a procedure that results in death,” she explained.